CRENESSITY
Live / Registered — Registered (as of 01 Sept 2026)
What this means for you
Registered since 01 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Sept 2032: the §8 declaration of use).
Record
- Serial number
- 99975552
- Registration number
- 8427932
- Mark type
- Design + words
- Filed
- 29 Jan 2025
- Published for opposition
- 15 Jul 2025
- Registered
- 01 Sept 2026
- Next maintenance filing
- §8 declaration of use, due by 01 Sept 2032 (grace period to 01 Mar 2033)
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
- Class 042 — Scientific and technological services: providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia
- Class 044 — Medical, beauty and agricultural services: Providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia; on-line information services, namely, providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 01 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 12 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Aug 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Aug 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Oct 2025 — USE AMENDMENT FILED
- 22 Jul 2026 — DIVISIONAL PROCESSING COMPLETE
- 03 Oct 2025 — DIVISIONAL REQUEST RECEIVED
- 22 Jul 2026 — SOU EXTENSION 1 GRANTED
- 09 Mar 2026 — SOU EXTENSION 1 FILED
- 17 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Oct 2025 — TEAS REQUEST TO DIVIDE RECEIVED